NO865162L - Fremgangsmaate for fremstilling av en ekstemporaer homogen mikrokapselsuspensjon. - Google Patents

Fremgangsmaate for fremstilling av en ekstemporaer homogen mikrokapselsuspensjon.

Info

Publication number
NO865162L
NO865162L NO865162A NO865162A NO865162L NO 865162 L NO865162 L NO 865162L NO 865162 A NO865162 A NO 865162A NO 865162 A NO865162 A NO 865162A NO 865162 L NO865162 L NO 865162L
Authority
NO
Norway
Prior art keywords
exemporary
homogenic
procedure
preparation
microcapsule suspension
Prior art date
Application number
NO865162A
Other languages
English (en)
Other versions
NO171949C (no
NO171949B (no
Inventor
Massimo Calanchi
Leonardo Gentilini
Marco Marconi
Original Assignee
Eurand Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Spa filed Critical Eurand Spa
Publication of NO865162L publication Critical patent/NO865162L/no
Publication of NO171949B publication Critical patent/NO171949B/no
Publication of NO171949C publication Critical patent/NO171949C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2989—Microcapsule with solid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO865162A 1985-05-08 1986-12-18 Fremgangsmaate for fremstilling av et farmasoeytisk mikroinnkapslet preparat NO171949C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20617/85A IT1183574B (it) 1985-05-08 1985-05-08 Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
PCT/EP1986/000280 WO1986006626A1 (en) 1985-05-08 1986-05-02 Method of preparing an extemporaneous homogeneous microcapsule suspension

Publications (3)

Publication Number Publication Date
NO865162L true NO865162L (no) 1986-12-18
NO171949B NO171949B (no) 1993-02-15
NO171949C NO171949C (no) 1993-05-26

Family

ID=11169617

Family Applications (1)

Application Number Title Priority Date Filing Date
NO865162A NO171949C (no) 1985-05-08 1986-12-18 Fremgangsmaate for fremstilling av et farmasoeytisk mikroinnkapslet preparat

Country Status (19)

Country Link
US (1) US5008117A (no)
EP (1) EP0222856B1 (no)
JP (1) JP2609597B2 (no)
KR (1) KR900000212B1 (no)
AT (1) ATE59287T1 (no)
AU (1) AU589644B2 (no)
CA (1) CA1274144A (no)
DE (1) DE3676642D1 (no)
DK (1) DK157730C (no)
ES (1) ES8707103A1 (no)
FI (1) FI86596C (no)
HU (1) HUT44168A (no)
IT (1) IT1183574B (no)
NO (1) NO171949C (no)
NZ (1) NZ216062A (no)
PT (1) PT82541B (no)
RU (1) RU2059409C1 (no)
WO (1) WO1986006626A1 (no)
ZA (1) ZA863399B (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
US5064650A (en) * 1988-04-19 1991-11-12 Southwest Research Institute Controlled-release salt sensitive capsule for oral use and adhesive system
AU618096B2 (en) * 1988-04-19 1991-12-12 Southwest Research Institute Controlled release of active ingredients from capsules having a salt sensitive shell material
FR2634376B1 (fr) 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation
IT1246350B (it) * 1990-07-11 1994-11-17 Eurand Int Metodo per ottenere una rapida sospensione in acqua di farmaci insolubili
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
US5252337A (en) * 1991-06-25 1993-10-12 Eurand America, Inc. Controlled release calcium channel blocker microcapsules
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
MX9301821A (es) * 1992-03-30 1994-03-31 Alza Corp Sistema de matriz polimerica biodegradable regulador de degradacion y metodo de tratamiento del mismo.
ZA932272B (en) * 1992-03-30 1993-10-19 Alza Corp Viscous suspensions of controlled-release drug particles
HU215958B (hu) * 1992-04-30 1999-03-29 Schering Corp. Eljárás stabil, hidratált, száraz ceftibuten porkészítmény előállítására perorális szuszpenziókhoz
US5422122A (en) * 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
FI941777L (fi) * 1993-04-16 1994-10-17 Mcneil Ppc Inc Vesipitoinen farmaseuttinen suspensio ja menetelmä sen valmistamiseksi
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water
RU2147923C1 (ru) * 1997-12-02 2000-04-27 Ивановский государственный университет Способ получения микрокапсул
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
US6699315B2 (en) 2000-11-28 2004-03-02 Fmc Corporation Edible PGA coating composition
PL362979A1 (en) * 2000-12-11 2004-11-02 Takeda Chemical Industries, Ltd. Medicinal compositions improved in solublity in water
JP2004168703A (ja) * 2002-11-20 2004-06-17 Shin Etsu Chem Co Ltd マイクロカプセル及びその製造方法
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
US20050118194A1 (en) * 2003-12-01 2005-06-02 Sin Yoke M. Oral vaccine, method for its preparation and use thereof
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
PL3568122T3 (pl) * 2017-01-10 2024-03-18 Dukebox Sp. Z O.O. Sposób wytwarzania zawiesiny nanocząsteczek soli potasowej albo soli magnezowej
AR118418A1 (es) 2019-02-22 2021-10-06 Catalent Uk Swindon Zydis Ltd Conservación de partículas ifa revestidas funcionalmente producidas mediante procesos de mezcla sin solvente en suspensión acuosa
BR112021016485A2 (pt) 2019-02-22 2021-10-13 Catalent U.K. Swindon Zydis Limited Minimização de aglomeração de material de revestimento de partícula de fármaco durante armazenamento para estabilizar tempos de desintegração de produtos farmacêuticos
CN113490486B (zh) 2019-02-22 2025-10-17 康特伦英国斯温顿捷迪斯有限公司 最小化团聚、曝气和保持包含布洛芬的药物组合物的包衣
CA3129383A1 (en) * 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Minimizing aeration of suspensions during in-line mixing
RU2731599C1 (ru) * 2019-07-17 2020-09-04 Общество с ограниченной ответственностью "РУСИНТЕХ" Способ получения микрокапсулированного термоактивируемого огнегасящего агента
MX2023001004A (es) 2020-07-31 2023-03-01 Catalent Uk Swindon Zydis Ltd Composiciones farmaceuticas que comprenden un ingrediente farmaceutico activo (api) recubierto.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB844772A (en) * 1956-04-19 1960-08-17 Pfizer & Co C Granular pharmaceutical compositions and process for preparing same
FR2077696B1 (no) * 1970-02-06 1973-03-16 Synthelabo
DE2211019C3 (de) * 1972-03-08 1980-08-28 Bayer Ag, 5090 Leverkusen Geschmacksverbessernde Formulierungen oraler Penicilline
US4155741A (en) * 1974-05-01 1979-05-22 Stauffer Chemical Company Stable suspension system for microencapsulated flowable formulations, and method of preparing stable suspension of microcapsules
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4189499A (en) * 1977-03-16 1980-02-19 Biochefarm S.A. Lysine 4-allyloxy-3-chlorophenylacetate and method of its preparation
IT1148784B (it) * 1980-04-09 1986-12-03 Eurand Spa Procedimento per la preparazione di microcapsule in un veicolo liquido
IT1209276B (it) * 1980-11-05 1989-07-16 Magis Farmaceutici Composizione farmaceutica per la somministrazione orale del metilestere dell'acido 13a-etil-2,3,5,6,12,13,13a,13b-ottaidro-12-idrossi1h-indolo-[3,2,1-de] pirido [3,2,1-ij] [1,5] naftiridina -12-carbossilico

Also Published As

Publication number Publication date
US5008117A (en) 1991-04-16
KR870700209A (ko) 1987-05-30
PT82541A (en) 1986-06-01
DK157730C (da) 1990-07-16
DE3676642D1 (de) 1991-02-07
AU5903186A (en) 1986-12-04
DK7487D0 (da) 1987-01-07
EP0222856B1 (en) 1990-12-27
RU2059409C1 (ru) 1996-05-10
CA1274144A (en) 1990-09-18
ES554777A0 (es) 1987-07-16
DK7487A (da) 1987-01-07
JPS62502859A (ja) 1987-11-12
ZA863399B (en) 1987-01-28
EP0222856A1 (en) 1987-05-27
AU589644B2 (en) 1989-10-19
WO1986006626A1 (en) 1986-11-20
NO171949C (no) 1993-05-26
HUT44168A (en) 1988-02-29
FI865336A0 (fi) 1986-12-30
NZ216062A (en) 1989-07-27
FI865336L (fi) 1986-12-30
ES8707103A1 (es) 1987-07-16
NO171949B (no) 1993-02-15
JP2609597B2 (ja) 1997-05-14
FI86596B (fi) 1992-06-15
KR900000212B1 (ko) 1990-01-23
ATE59287T1 (de) 1991-01-15
DK157730B (da) 1990-02-12
IT8520617A0 (it) 1985-05-08
IT1183574B (it) 1987-10-22
PT82541B (pt) 1988-03-03
FI86596C (fi) 1992-09-25

Similar Documents

Publication Publication Date Title
FI865336A0 (fi) Foerfarande foer framstaellning av en snabbt framstaellbar homogen mikrokapselsuspension.
DK158718C (da) Fremgangsmaade til flokkulation af suspenderede faste stoffer i en vandig suspension
BG42000A3 (en) Method for preparing suspension of microcapsulated bacampicilline salt of acid incorporation
ES8400029A1 (es) Procedimiento para la preparacion de una suspension hidroalcoholica.
BR9916691A (pt) Processo para preparação de partìculas de amido em um sistema de duas fases
GB2198947B (en) Method for facilitating the formation of lipidic spherules dispersed in an aqueous phase and for improving their stability and degree of encapsulation
PT1210068E (pt) Utilizacao de aminoacidos simples para formar particulas porosas
MX170356B (es) Agente acondicionador y las composiciones que lo contienen
NO881625L (no) Fremgangsmaate for fremstilling av stabile sucralfatsuspensjoner.
ES2052671T3 (es) Agente en forma de particulas, adecuado para la separacion selectiva de cationes metalicos a partir de soluciones acuosas, procedimiento para su preparacion y su empleo.
FI873092L (fi) Polymeerihiukkanen sekä sen vesidispersio, valmistusmenetelmä ja käyttö
IL88054A0 (en) Stable aqueous dispersions of water-insoluble particulate solids and processes for the preparation thereof
AR083451A2 (es) Metodo para preparar una suspension farmaceutica acuosa de nevirapina, dicha suspension farmaceutica y uso de nevirapina para preparar dicha suspension farmaceutica
BR9904286A (pt) Suspensões antiácidas e antigás termoestáveis
Glovsky et al. Coagulation related deficiencies of early components of C (C1, C4, C2) in human serum
FR2657010B1 (fr) Composition pharmaceutique sous forme de suspension aqueuse stable a base de sucrafalte et d'une substance anti-acide ainsi que son procede de preparation.
JPS57207589A (en) Flocculating method for protein existing in solution or suspension state
DE59906985D1 (de) Aluminiumsilikatsuspension
Kondo CELL‐BINDING SUBSTANCES IN SEA URCHIN EMBRYOS
DK565486A (da) Carboxylgruppeholdige polyamider, fremgangsmaader til fremstilling heraf samt deres anvendelse til fremstilling af vandige bronzedispersioner
ATE300956T1 (de) Anwendung und herstellungsverfahren von tierischen gammaglobulin-reichen plasmaprotein mischungen
Zentner et al. Free fatty acid-induced platelet aggregation: studies with solubilized and nonsolubilized fatty acids
KR870008789A (ko) 탄산칼슘 표면 처리방법
ID20479A (id) Penggunaan garam-garam asam poliaspartat sebagai sarana penggilingan
KR840002018A (ko) 입자상 고체물질의 수성현탁액 제조방법

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2003